These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16322772)

  • 1. Hopkins scientist tunes in to treat tuberculosis.
    Bloom S
    J Clin Invest; 2005 Dec; 115(12):3302-3. PubMed ID: 16322772
    [No Abstract]   [Full Text] [Related]  

  • 2. Moxifloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
    [No Abstract]   [Full Text] [Related]  

  • 3. Promising results for new tuberculosis therapy.
    Bagchi S
    CMAJ; 2008 Jan; 178(1):19. PubMed ID: 18166722
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational use of moxifloxacin for tuberculosis treatment.
    Cox H; Ford N; Keshavjee S; McDermid C; von Schoen-Angerer T; Mitnick C; Goemaere E
    Lancet Infect Dis; 2011 Apr; 11(4):259-60. PubMed ID: 21453864
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxifloxacin for tuberculosis.
    Singh KP; Brown M; Murphy ME; Gillespie SH
    Lancet Infect Dis; 2012 Mar; 12(3):176; author reply 177-8. PubMed ID: 22361420
    [No Abstract]   [Full Text] [Related]  

  • 6. Moxifloxacin for tuberculosis.
    Mendel C; Springsklee M
    Lancet Infect Dis; 2012 Mar; 12(3):176-7; author reply 177-8. PubMed ID: 22361419
    [No Abstract]   [Full Text] [Related]  

  • 7. Doctors report breakthrough antibiotic treatment for TB.
    AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug combo speeds up TB treatment.
    AIDS Patient Care STDS; 2007 Oct; 21(10):783-4. PubMed ID: 17949277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
    Mozhokina GN; Sokolova GB; Dashieva DG; Mikhaĭlova LP; Elistratova NA
    Probl Tuberk Bolezn Legk; 2005; (2):19-22. PubMed ID: 15881962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug-resistant tuberculosis.
    Dheda K; Shean K; Badri M
    N Engl J Med; 2008 Nov; 359(22):2390; author reply 2391. PubMed ID: 19038886
    [No Abstract]   [Full Text] [Related]  

  • 11. Moxifloxacin treatment of tuberculosis.
    Gosling R; Gillespie S
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3642; author reply 3642-3. PubMed ID: 15328148
    [No Abstract]   [Full Text] [Related]  

  • 12. PanACEA: a new approach to tuberculosis research.
    Burki T
    Lancet Infect Dis; 2012 Mar; 12(3):184-5. PubMed ID: 22468276
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug combination for TB is tested in unique trial.
    Kmietowicz Z
    BMJ; 2012 Jul; 345():e5060. PubMed ID: 22833631
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.
    Roberts CH; Smith C; Breen R; Gadhok R; Murphy M; Aryee A; Cropley I; Bhagani S; Hopkins S; Lipman M
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1275-6. PubMed ID: 21943863
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel drug combination for tuberculosis to be tested across 50 sites.
    Bagcchi S
    BMJ; 2014 May; 348():g3535. PubMed ID: 24868091
    [No Abstract]   [Full Text] [Related]  

  • 16. Moxifloxacin versus ethambutol in initial tuberculosis treatment.
    Chang KC; Leung CC
    Lancet; 2009 Jun; 373(9682):2197-8; author reply 2198-9. PubMed ID: 19560596
    [No Abstract]   [Full Text] [Related]  

  • 17. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].
    Azaev MSh; Agafonov AP; Bodnev SA; Blinov VM
    Antibiot Khimioter; 2006; 51(11-12):7-10. PubMed ID: 18318141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
    Ahmad Z; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2008 Feb; 31(2):142-6. PubMed ID: 18155883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in tuberculosis 2009.
    Daley CL
    Am J Respir Crit Care Med; 2010 Mar; 181(6):550-5. PubMed ID: 20208041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.